Investigating the Safety, Tolerability, Immunogenicity and Pharmacokinetics of Olamkicept in Healthy Japanese Persons

NCT06515834 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastroenterology

Interventions

DRUG: FE 999301
DRUG: Placebo

Sponsor

Ferring Pharmaceuticals